Hormonal therapy of breast cancer

Cancer Treat Rev. 1998 Jun;24(3):221-40. doi: 10.1016/s0305-7372(98)90051-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors
  • Breast Neoplasms / drug therapy*
  • Drug Resistance, Neoplasm
  • Enzyme Inhibitors / therapeutic use
  • Estrogen Antagonists / therapeutic use
  • Estrogens / analysis
  • Female
  • Forecasting
  • Gonadotropin-Releasing Hormone / therapeutic use
  • Humans
  • Progestins / therapeutic use
  • Receptors, Estrogen / analysis
  • Receptors, Estrogen / antagonists & inhibitors
  • Receptors, Progesterone / analysis
  • Receptors, Progesterone / antagonists & inhibitors
  • Survival Rate
  • Tamoxifen / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Enzyme Inhibitors
  • Estrogen Antagonists
  • Estrogens
  • Progestins
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Tamoxifen
  • Gonadotropin-Releasing Hormone